Funded Symptom Science Grants

Active/Completed

Topics

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Goode, Diana J	University Of New England United States	Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy	5R01CA267554-03	Rachel Altshuler, Ph.D.
Goode, Diana J	University Of New England United States	Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy	5R01CA267554-03	Rachel Altshuler, Ph.D.
Groninger, J. Hunter	Medstar Health Research Institute United States	Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing	1R21CA299799-01	Brennan Streck, Ph.D., RN, M.P.H.
Groninger, J. Hunter	Medstar Health Research Institute United States	Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing	1R21CA299799-01	Brennan Streck, Ph.D., RN, M.P.H.
Gross, Howard M	Dayton Clinical Oncology Program United States	Dayton Clinical Oncology Program	5UG1CA189957-11	Vanessa A. White, M.P.H.
Gross, Howard M	Dayton Clinical Oncology Program United States	Dayton Clinical Oncology Program	5UG1CA189957-11	Vanessa A. White, M.P.H.
Grueber, Wesley B	Columbia University Health Sciences United States	Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy	5R21CA274588-02	Rachel Altshuler, Ph.D.
Grueber, Wesley B	Columbia University Health Sciences United States	Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy	5R21CA274588-02	Rachel Altshuler, Ph.D.
Hall, Daniel Lee	Massachusetts General Hospital United States	Innovating CBT-I for Cancer Survivors: An Optimization Trial	5R21CA279248-02
Hall, Daniel Lee	Massachusetts General Hospital United States	Innovating CBT-I for Cancer Survivors: An Optimization Trial	5R21CA279248-02
Halmos, Balazs	Montefiore Medical Center (Bronx, Ny) United States	MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM	5UG1CA189859-11	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Halmos, Balazs	Montefiore Medical Center (Bronx, Ny) United States	MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM	5UG1CA189859-11	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Hanks, Brent Allen	Univ Of North Carolina Chapel Hill United States	Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities	7R01CA251136-05	Marjorie Perloff, M.D.
Hanks, Brent Allen	Univ Of North Carolina Chapel Hill United States	Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities	7R01CA251136-05	Marjorie Perloff, M.D.
Harichand, Seema	Iowa Oncology Research Association United States	Iowa-Wide Oncology Research Coalition (I-WORC)	5UG1CA189816-11	Vanessa A. White, M.P.H.